Article: A novel treatment option in chronic myeloid leukaemia: Asciminib

Related products

• 

  Article: Highlights in melanoma

  €3.03 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €3.03 Add to cart
• 

  Article: Calendar of events

  €3.03 Add to cart
• 

  Article: Highlights in melanoma

  €3.03 Add to cart